Clinical Trials Sponsored by Iris Pharma

Total 8379 results

Laclaree
Iris Pharma

Completed

Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia (eve-1)

Presbyopia

France
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
Laboratoires Thea
Iris Pharma

Completed

Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment

Dry Eye

United Kingdom
Tris Pharma, Inc.

Completed

Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic

Diabetic Polyneuropathy

Germany, United Kingdom
Tris Pharma, Inc.

Terminated

CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer (CORAL)

Neoplasms | Pain | Chronic Pain

Croatia, Austria, Belgium, Bulgaria, Denmark, Germany, Hungary, Poland, Romania, Serbia, Slovakia, Chile, Spain, United Kingdom
Tris Pharma, Inc.

Completed

TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

United States
Tris Pharma, Inc.

Completed

Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Study

Attention Deficit Hyperactivity Disorder

United States
Tris Pharma, Inc.

Completed

Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain.

Pain

Netherlands
Tris Pharma, Inc.

Completed

Assessment of Abuse Potential of Cebranopadol in Humans

Human Abuse Potential

United States
Tris Pharma, Inc.

Completed

A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users

Abuse, Drug

Canada
Tris Pharma, Inc.

Completed

Bunionectomy Trial With GRT6005

Post Operative Pain

United States
Tris Pharma, Inc.

Completed

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

Diabetes Mellitus | Diabetic Neuropathies | Chronic Pain

France, Spain, Austria, United States, Denmark, Germany, Italy, Netherlands
Tris Pharma, Inc.

Completed

CORAL XT - Open-label Extension Trial of the CORAL Trial (CORAL XT)

Neoplasms | Pain | Chronic Pain

Austria, Belgium, Bulgaria, Denmark, Germany, Hungary, Poland, Romania, Serbia, Slovakia
Tris Pharma, Inc.

Completed

Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years

Attention Deficit Hyperactivity Disorder

United States
Laboratoires Thea
Iris Pharma; Axial Biotech, Inc

Completed

Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice (MEIBUM)

Meibomian Gland Dysfunction | Ocular Surface Disease | Palpebral Pathologies

Germany, Spain
Tris Pharma, Inc.
Forest Laboratories

Completed

Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain.

Low Back Pain

Austria, Belgium, Denmark, Finland, Germany, Hungary, Netherlands, Poland, Spain, Sweden, United Kingdom
Tris Pharma, Inc.
Forest Laboratories

Completed

Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects

Prolonged QTc Interval | Pharmacokinetic

United States
Tris Pharma, Inc.
Forest Laboratories

Completed

Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy

Pain | Diabetic Neuropathies

Bulgaria, Germany, Romania
Tris Pharma, Inc.
Forest Laboratories

Completed

Assessment of GRT6005 in Painful Osteoarthritis of the Knee

Osteoarthritis of the Knee

Austria, Poland, Spain
Tris Pharma, Inc.
Forest Laboratories

Completed

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

United States
Tris Pharma, Inc.
Forest Laboratories

Completed

A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol

Pharmacokinetic

United States
IRIS Media Inc

Completed

ASD Parent Trainer: Online Coaching for Parents of Children With Autism (APT)

Autism Disorder

United States
Tris Pharma, Inc.
Premier Research Group plc

Completed

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

ADHD

United States
IRIS Media Inc
Spelman College

Completed

Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR) (CRSR)

Behavior

United States
Loughborough University
Natalia Iris

Recruiting

Understanding the Impact of Physical Activity Calorie Equivalent (PACE) Labelling in Secondary Schools

Eating Behaviour of Discretionary Foods

United Kingdom
Iris Sommer

Unknown

Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations (tDCS)

Personality Disorders | Psychotic Disorders | Mood Disorders | Stress Disorders, Post-Traumatic | Hearing Disorders

Netherlands
Iris Sommer

Unknown

Understanding Hallucinations (Part II) (UH-2)

Hallucinations

Netherlands
Irise International

Completed

Does Menstrual Hygiene Matter? Investigating the Impact of a Menstrual Hygiene Program on Ugandan Girls' School Absenteeism

Menstrual Hygiene Management

Uganda
IRIS Research and Development, LLC
Mallinckrodt

Completed

Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) (CLIPS)

Psoriatic Arthritis

United States
Iris Sommer
Netherlands Brain Foundation

Withdrawn

Effect of Methylphenidate on Connectivity

Attention Deficit Hyperactivity Disorder

Netherlands
Fundacion Ibis

Unknown

Telemedicine in HIV Care in Buenos Aires

Telemedicine | HIV-1-infection
Xiao Jing (Iris) Wang
Mayo Clinic

Enrolling by invitation

Tradipitant for Functional Dyspepsia

Functional Dyspepsia

United States
Tris Pharma, Inc.
Massachusetts General Hospital; Massachusetts Institute of Technology

Completed

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
ISIS Diabete Service

Unknown

Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study (DEEP)

Diabetes Mellitus, Type 1 | Pediatric ALL

France
Iris Sommer
Stanley Medical Research Institute

Completed

Simvastatin Addition for Patients With Recent-onset Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis NOS

Netherlands
Fundacion CRIS de Investigación para Vencer el...
Amgen

Completed

Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes | Immune Thrombocytopenia

Spain
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Kris Jatana

Completed

Endotracheal Tube Intracuff Pressure and Leak

Otolaryngological Surgery

United States
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
University of Vic - Central University of Catalonia
IRIS-CC; AGAUR

Enrolling by invitation

Mental Health and Vigorous-intensity Physical Activity (+MoveMENT)

Mental Health Issue

Spain
University College Dublin
Irish Research Council

Recruiting

Umbilical or Peripheral Catheter Insertion for Preterm Infants on Admission to the NICU (UP)

Preterm Birth Complication | Neonatal Hypothermia | Hypothermia, Newborn

Ireland
Irish Research Radiation Oncology Group

Recruiting

Optimising Patient Experience in Head and Neck Radiotherapy (OPEN)

Head and Neck Cancer

Ireland
Kris Jatana

Withdrawn

Endotracheal Tube Intracuff Pressure and Leak Around the Cuff During Retractor Placement for Adenotonsillectomy

Otolaryngological Surgery

United States
Amanda Irish

Completed

Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-remitting

United States
Centre Hospitalier Universitaire Saint Pierre
Fonds iris-Recherche, Fondation Roi Baudouin, Belgium

Completed

Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder (OCT-HIV)

AIDS-Related Dementia Complex

Belgium
Ibis Reproductive Health
Marie Stopes International

Unknown

Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks

Medical Abortion

Mexico
University College Dublin
Irish Research Council

Completed

CopeSmart: Using Mobile Technology to Promote Positive Mental Health in Young People

General Mental Health and Well-Being

Ireland

Clinical Trials Sponsored by Iris Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations